Sugar-Based Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Sugar-Based Excipients Market is segmented by Product (Actual sugar, Sugar alcohols, and Artificial sweeteners), Type (Powders/Granules, Direct compression sugars, Crystals, and Others), Application (Fillers and Diluents, Flavoring agents, Tonicity agents, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Sugar-Based Excipients Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Sugar-Based Excipients Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.60 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Sugar-Based Excipients Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Sugar-Based Excipients Market Analysis

The sugar-based excipients market is projected to grow with a CAGR of 4.6% over the forecast period.

During the COVID-19 pandemic, pharmaceutical excipients companies faced significant problems, such as a shortage of medicinal items, and shutdown measures worldwide damaged the global supply chain of raw materials from manufacturing hubs. These restrictions hampered the medication research and manufacturing processes and had a significant impact on the corporations that rely on outsourcing. Moreover, the growing use of sugar-based excipients in the COVID-19 vaccines positively impacted the market. For instance, according to the review by the Connecticut Department of Health in April 2021, the Pfizer-BioNTech vaccine contains basic table sugar, generally known as sucrose, which is used as a stabilizer in vaccines. This component aids in the preservation of the molecules' form upon freezing. Thus, during the COVID-19 pandemic, the sugar-based excipients market is expected to have an adverse impact initially, later due to the use of sugar-based excipients in COVID-19 drug and vaccine formulations which is likely to gain market growth over the study period.

The major factor attributing to the growth of the market is the increasing use of co-processed excipients, the rapid growth of the generic market, and the increasing development of orally disintegrating tablets. For instance, as per the report published by the journal of APhP in December 2022, new combinations of existing excipients are an interesting option for improving excipient functionality which includes pleasant taste, mouth feel, and sweetness in orally disintegrating tablets. Thus, due to the above benefits of the co-processed excipient, the demand for sugar-based excipients is expected to grow, as it is one of the ingredients in the pharmaceutical product, thereby boosting the market growth.

Furthermore, the growing preference for orally disintegrating tablets and their development is boosting the market. Orally disintegrating tablets differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. As the number of geriatric population and pediatric patients increases, the demand for orally disintegrating tablets is increasing. For instance, according to the study published by MDPI in August 2022, saccharides and sugar alcohols have long been of interest in the area of orodispersible formulations due to their high-water solubility and taste-improving properties. As a result, several excipient combinations developed to manufacture orally dispersible dosage forms contain monosaccharides and/or their respective alcohols. Sugars or sugar alcohols, together with other excipients, are used to ensure the tablets' uniformity and structural integrity. The market for sugar-based excipients is therefore projected to rise as a result of the aforementioned advantages of sugar-based excipients in orally dispersible tablets.

However, the stringent regulatory requirements for sugar-based excipient products are expected to restrain market growth.

Sugar-Based Excipients Market Trends

This section covers the major market trends shaping the Sugar-Based Excipients Market according to our research experts:

Sugar Alcohol Segment is Expected to have Largest Share in the Market Over the Forecast Period

The sugar alcohol segment is expected to account for the largest share in the global market owing to its increased utilization in oral prescription medicines and pediatric formulations due to its non-toxicity and high efficiency. Sugar alcohols, also known as polyols, are ingredients used as sweeteners and bulking agents. They can be used to conceal the bitter taste of active agents, thereby making them more palatable.

The major factors increasing the market growth of the segment are the increasing birth rate and the growing pediatric patient pool. The actual sugars are used mainly in oral formulations due to their non-toxicity and negligible reaction with drugs. According to Childstats.gov 2022, the number of children aged 0-17 years in the United States is estimated at 73.6 million in 2021 and is likely to increase to 78.2 million by 2050. Thus, increasing the pediatric population is expected to drive the demand for sugar-based formulations, thereby boosting segment growth.

Additionally, some of the additional advantages of sugar alcohols in the pharmaceutical field help in the growth of the segment. For instance, as per the report published by the AAPS Journal in January 2022, when taken orally, the sugar alcohols sorbitol and mannitol are known to provide a strong osmotic effect. Hence, widespread applications of sugar alcohols it is expected to drive the market over the forecast period.

Sugar-Based Excipients Market : Number of Children (In Millions), By Age, United States, 2021

North America is Expected to have Significant Growth in the Market Over the Forecast Period

North America is expected to have significant growth in the sugar-based excipients market and is likely to maintain this over the forecast period. Factors such as the rapidly expanding pharmaceutical sector, the rising need for functional excipients, the presence of significant players in the region, and technological advances will drive market expansion throughout the projection period.

According to the report published by CDC in November 2021, sugar-based excipients are used as stabilizers to keep the vaccine potent during transportation and storage. Also, as per the same above-mentioned source, some of the vaccines in which sucrose is used as an excipient include Influenza (Afluria)Quadrivalent, Influenza (FluMist) Quadrivalent, MenB (Bexsero), MMRV (ProQuad), and Rotavirus (RotaTeq). Hence, the wide usage of these sugar-based excipients in the region as stabilizers is expected to drive the market over the forecast period.

Furthermore, strategic actions done by market participants, such as product launches, mergers, and acquisitions, contribute to the market segment's growth. For instance, in December 2021, Roquette Group intensified its pharmaceutical business expansion in the Americas to consolidate its worldwide leadership and underline its commitment to customer-focused innovation. Hence, these strategic actions of the major market players help in the widespread of the products in the region and are expected to boost the market over the study period.

Sugar-Based Excipients Market : Growth Rate by Region

Sugar-Based Excipients Industry Overview

The Sugar-Based Excipients market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are DFE Pharma, Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation, Associated British Foods PLC, Cargill, Inc., Colorcon Inc., FMC Corporation, and Meggle AG.

Sugar-Based Excipients Market Leaders

  1. Archer Daniels Midland Company

  2. Ashland Inc.

  3. Roquette Group

  4. The Lubrizol Corporation

  5. DFE Pharma

*Disclaimer: Major Players sorted in no particular order

Sugar-Based Excipients Market.png
Need More Details on Market Players and Competitors?
Download PDF

Sugar-Based Excipients Market News

  • November 2022: Roquette launched two next-generation mannitol products, Pearlitol CR-H and Pearlitol 200 GT, for direct compression.
  • July 2022: DFE Pharma, a manufacturer of pharma and nutraceutical excipient solutions, reported the expansion of its Dry Powder Inhalation (DPI) portfolio with the launch of Lactohale 400.

Sugar-Based Excipients Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Use of Co-processed Excipients
    • 4.2.2 Rapid Growth in the Generics Market
    • 4.2.3 Increasing Development of Orally Disintegrating Tablets
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Requirements
  • 4.4 Porter Five Forces
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Actual Sugar
    • 5.1.2 Sugar Alcohols
    • 5.1.3 Artificial Sweeteners
  • 5.2 By Type
    • 5.2.1 Powders/Granules
    • 5.2.2 Direct Compression Sugars
    • 5.2.3 Crystals
    • 5.2.4 Others
  • 5.3 By Application
    • 5.3.1 Fillers and Diluents
    • 5.3.2 Flavoring Agents
    • 5.3.3 Tonicity Agents
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 DFE Pharma (Royal FrieslandCampina)
    • 6.1.2 Archer Daniels Midland Company
    • 6.1.3 Ashland Inc.
    • 6.1.4 Roquette Group
    • 6.1.5 The Lubrizol Corporation
    • 6.1.6 Associated British Foods PLC
    • 6.1.7 Cargill, Inc.
    • 6.1.8 Colorcon Inc.
    • 6.1.9 MEGGLE Group GmbH
    • 6.1.10 DuPont de Nemours, Inc.
    • 6.1.11 Innophos
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Develop
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Sugar-Based Excipients Industry Segmentation

As per the scope of the report, the excipient is a pharmacologically inert element formulated together with the active ingredient of the medication. This is done with the purpose of providing substance to the formulation, providing prevention and stability from denaturation, facilitating the absorption of drugs by a patient, and other pharmacokinetic considerations. The Sugar-Based Excipients Market is segmented by Product (Actual sugar, Sugar alcohols, and Artificial sweeteners), Type (Powders/Granules, Direct compression sugars, Crystals, and Others), Application (Fillers and Diluents, Flavoring agents, Tonicity agents, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Actual Sugar
Sugar Alcohols
Artificial Sweeteners
By Type Powders/Granules
Direct Compression Sugars
Crystals
Others
By Application Fillers and Diluents
Flavoring Agents
Tonicity Agents
Others
Geography North America United States
Canada
Mexico
Geography Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Geography Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
Geography South America Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Sugar-Based Excipients Market Research FAQs

The Global Sugar-Based Excipients Market is projected to register a CAGR of 4.60% during the forecast period (2024-2029)

Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation and DFE Pharma are the major companies operating in the Global Sugar-Based Excipients Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Sugar-Based Excipients Market.

The report covers the Global Sugar-Based Excipients Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Sugar-Based Excipients Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Global Sugar-Based Excipients Industry Report

Statistics for the 2024 Global Sugar-Based Excipients market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Sugar-Based Excipients analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Sugar-Based Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)